Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BG Medicine Inc BGMD

Metals & Mining Technology Industrial Metals & Minerals Scientific & Technical Instruments
BG Medicine, Inc. (BG Medicine) is a commercial-stage diagnostics company. The Company is engaged in commercializing diagnostic products that may be used to help guide the care and management of patients suffering from heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that employs a manual micro-titer platform to measure galectin-3 levels in... see more

Recent & Breaking News (GREY:BGMD)

BG Medicine Withdraws 510(k) Premarket Notification for Proposed Additional Indication for the BGM Galectin-3® Test

GlobeNewswire December 23, 2015

License and Distribution Agreement Amended

GlobeNewswire November 30, 2015

BG Medicine Reports Third Quarter 2015 Financial Results

GlobeNewswire November 17, 2015

BG Medicine Announces Business Update Conference Call Information

GlobeNewswire November 11, 2015

BG Medicine Due Diligence Report: Quietly Making Headway - Broad Street Alerts

Accesswire November 5, 2015

BG Medicine to Begin Trading on the OTCQB

GlobeNewswire September 15, 2015

BG Medicine Provides Business Update and Reports Second Quarter 2015 Financial Results

GlobeNewswire August 14, 2015

BG Medicine Prices Underwritten Public Offering

GlobeNewswire August 13, 2015

BG Medicine Announces Proposed Underwritten Public Offering

GlobeNewswire August 12, 2015

BG Medicine Welcomes U.S. Market Introduction of Automated Galectin-3 Test at the 2015 American Association for Clinical Chemistry Annual Meeting

GlobeNewswire July 27, 2015

BG Medicine Announces Payoff of Secured Term Loan

GlobeNewswire July 15, 2015

BG Medicine Announces One-for-Four Reverse Stock Split

GlobeNewswire July 8, 2015

First Automated Test for Galectin-3 Now Available in U.S.

GlobeNewswire July 6, 2015

BG Medicine Reports First Quarter 2015 Financial Results

GlobeNewswire May 14, 2015

BG Medicine Announces Q1 2015 Financial Results Release Date and Conference Call Information

GlobeNewswire May 7, 2015

BG Medicine Submits 510(k) to FDA for Additional Indication for the BGM Galectin-3(R) Test

GlobeNewswire March 31, 2015

BG Medicine Reports 2014 Fourth Quarter and Year End Financial Results

GlobeNewswire March 31, 2015

BG Medicine Welcomes Major Publication on the BioImage Study in the Journal of the American College of Cardiology

GlobeNewswire March 26, 2015

BG Medicine Announces Fiscal Year 2014 Financial Results Release Date and Conference Call Information

GlobeNewswire March 24, 2015

BG Medicine Announces Receipt of NASDAQ Notice of Non-Compliance; Intends to Request Hearing and Seek Extension

GlobeNewswire March 13, 2015